Advertisement
Screener

Quanterix Corporation (QTRX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Quanterix Corporation Cash Flow Breakdown

Cash flow breakdown shows where Quanterix Corporation's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $77.24M went out.
  • Fiscal year ended 2025-12-31: from investing, $50.23M came in.
  • Fiscal year ended 2025-12-31: from financing, $708.00K went out.
  • Fiscal year ended 2025-12-31: change in cash, $27.71M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$77.24M$50.23M-$1.45M$738.00K*-$27.71M
2024-12-31-$35.16M-$82.27M-$2.61M*-$116.97M
2023-12-31-$18.85M-$148.45M-$198.00K$2.89M*-$164.61M
2022-12-31-$48.61M-$11.09M$0.00$1.43M$881.00K*-$57.17M
2021-12-31-$47.62M-$6.40M$0.00$7.75M$263.05M*$216.55M
2020-12-31-$23.36M-$626.00K$4.02M$92.22M*$72.25M
2019-12-31-$26.19M-$25.38M$2.82M$113.38M*$64.63M
2018-12-31-$28.72M-$5.45M-$20.00K-$34.25M
2017-12-31-$22.11M-$1.13M$8.42M$64.83M*$50.01M
2016-12-31-$17.74M-$826.00K$45.43M$27.35M

Each quarter (3 month)

Quarter endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$5.12M*$13.66M*$0.00*-$527.00K*
2026-03-31-$18.11M$25.26M-$27.00K-$743.00K*$6.39M
2025-12-31-$16.44M*$8.44M*-$436.00K*
2025-09-30-$41.25M*-$52.85M*-$6.00K*
2025-06-30-$5.66M*$61.88M*-$429.00K*
2025-03-31-$13.89M$32.76M-$575.00K*$18.97M
2024-12-31-$4.30M*$32.38M*-$26.00K*
2024-09-30-$5.75M*-$12.43M*-$434.00K*
2024-06-30-$4.95M*$6.97M*-$712.00K*
2024-03-31-$20.16M-$109.19M-$1.44M$2.04M*-$128.76M
2023-12-31-$6.19M*-$21.38M*-$56.00K*
2023-09-30-$3.87M*-$126.13M*-$55.00K*$1.85M*
2023-06-30$1.03M*-$811.00K*-$74.00K*
2023-03-31-$9.82M-$136.00K-$13.00K$13.00K$551.00K*-$9.41M
2022-12-31-$4.09M*-$1.59M*$714.00K*
2022-09-30-$14.80M*-$3.68M*$120.00K*
2022-06-30-$7.96M*-$5.01M*$211.00K*
2022-03-31-$21.75M-$815.00K$385.00K$594.00K*-$21.59M
2021-12-31-$10.01M*-$2.25M*$1.14M*-$1.99M*
2021-09-30-$13.78M*-$2.02M*$0.00*-$4.06M*
2021-06-30-$9.75M*-$4.56M*$0.00*$2.39M*
2021-03-31-$14.09M$2.44M$269.72M$3.60M*$261.66M
2020-12-31$4.65M*$1.52M*$2.08M*
2020-09-30-$7.42M*-$788.00K*$832.00K*$91.85M*
2020-06-30-$7.42M*-$935.00K*$615.00K*
2020-03-31-$13.18M-$426.00K$496.00K-$12.74M
2019-12-31-$4.54M*-$544.00K*$644.00K*
2019-09-30-$8.83M*-$15.00M*$266.00K*$64.94M*
2019-06-30-$7.47M*-$3.91M*$1.41M*$48.03M*
2019-03-31-$5.35M-$5.92M$503.00K-$10.44M
2018-12-31-$8.11M*-$107.00K*$1.19M*
2018-09-30-$6.64M*-$1.66M*$0.00*
2018-06-30-$3.91M*-$242.00K*$0.00*-$606.00K*
2018-03-31-$10.06M-$3.45M-$53.00K-$888.00K*-$14.45M
2017-12-31-$4.40M*-$339.00K*$130.00K*$65.60M*
2017-09-30-$7.49M*-$130.00K*$12.00K*
2017-06-30-$6.23M*-$496.00K*$30.00K*$8.42M*
2017-03-31-$3.99M-$167.00K$30.00K-$979.00K*-$5.11M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15